Pascual M - Search Results

1

First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study.

Tschopp J, L'Huillier AG, Mombelli M, Mueller NJ, Khanna N, Garzoni C, Meloni D, Papadimitriou-Olivgeris M, Neofytos D, Hirsch HH, Schuurmans MM, Müller T, Berney T, Steiger J, Pascual M, Manuel O, van Delden C; Swiss Transplant Cohort Study (STCS). Tschopp J, et al. Among authors: pascual m. Am J Transplant. 2020 Oct;20(10):2876-2882. doi: 10.1111/ajt.16062. Epub 2020 Jun 9. Am J Transplant. 2020. PMID: 32412159 Free PMC article.

2

Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir.

Fellay J, Venetz JP, Pascual M, Aubert JD, Seudoux C, Meylan PR. Fellay J, et al. Among authors: pascual m. Am J Transplant. 2005 Jul;5(7):1781-2; author reply 1783. doi: 10.1111/j.1600-6143.2005.00936.x. Am J Transplant. 2005. PMID: 15943640 Free article. No abstract available.

3

2005 immunosuppressive strategies in kidney transplantation: which role for the calcineurin inhibitors?

Wong W, Venetz JP, Tolkoff-Rubin N, Pascual M. Wong W, et al. Among authors: pascual m. Transplantation. 2005 Aug 15;80(3):289-96. doi: 10.1097/01.tp.0000168436.76784.45. Transplantation. 2005. PMID: 16082321 Review.

4

Humoral rejection of organ allografts.

Moll S, Pascual M. Moll S, et al. Among authors: pascual m. Am J Transplant. 2005 Nov;5(11):2611-8. doi: 10.1111/j.1600-6143.2005.01086.x. Am J Transplant. 2005. PMID: 16212619 Free article. Review.

5

Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation.

Wong W, Agrawal N, Pascual M, Anderson DC, Hirsch HH, Fujimoto K, Cardarelli F, Winkelmayer WC, Cosimi AB, Tolkoff-Rubin N. Wong W, et al. Among authors: pascual m. Transpl Int. 2006 Aug;19(8):629-35. doi: 10.1111/j.1432-2277.2006.00270.x. Transpl Int. 2006. PMID: 16827679 Free article. Clinical Trial.

6

Preemptive versus prophylactic approaches in the management of cytomegalovirus disease in solid organ transplant recipients: what we know and what we do not know.

Meylan PR, Pascual M. Meylan PR, et al. Among authors: pascual m. Clin Infect Dis. 2006 Oct 1;43(7):881-3. doi: 10.1086/507338. Epub 2006 Aug 23. Clin Infect Dis. 2006. PMID: 16941369 No abstract available.

7

Drug-minimization or tolerance-promoting strategies in human kidney transplantation: is Campath-1H the way to follow?

Golshayan D, Pascual M. Golshayan D, et al. Among authors: pascual m. Transpl Int. 2006 Nov;19(11):881-4. doi: 10.1111/j.1432-2277.2006.00391.x. Transpl Int. 2006. PMID: 17018122 Free article. No abstract available.

8

From current immunosuppressive strategies to clinical tolerance of allografts.

Golshayan D, Buhler L, Lechler RI, Pascual M. Golshayan D, et al. Among authors: pascual m. Transpl Int. 2007 Jan;20(1):12-24. doi: 10.1111/j.1432-2277.2006.00401.x. Transpl Int. 2007. PMID: 17181648 Free article. Review.

9

Anti-HLA antibody repertoire after IVIg infusion in highly sensitized patients waiting for kidney transplantation.

Ferrari-Lacraz S, Aubert V, Buhler L, Pascual M, Andresen I, Binet I, Martin PY, Villard J. Ferrari-Lacraz S, et al. Among authors: pascual m. Swiss Med Wkly. 2006 Oct 28;136(43-44):696-702. doi: 10.4414/smw.2006.11517. Swiss Med Wkly. 2006. PMID: 17183432 Free article.

10

Oral valganciclovir for cytomegalovirus colitis after liver transplantation.

Manuel O, Meylan PR, Rotman S, Fontana M, Moradpour D, Pascual M. Manuel O, et al. Among authors: pascual m. Transplantation. 2007 Jan 27;83(2):239-40. doi: 10.1097/01.tp.0000242138.33261.ef. Transplantation. 2007. PMID: 17264825 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,299 results

Search Page